Evolent Health, Inc. (EVH)

NYQ – Real Time Price. Currency in USD

4.36

+0.26 (6.34%)

Market open: Aug 12, 2026, 12:31 PM EDT

4.13

+0.03 (0.73%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Stock details

Previous close: 4.1$
Day's range: 3.94 - 4.41$
52-week range: 2.1 - 10.08$
Volume: 4 838 387
Average volume: 4 258 930
Beta: 2.08
EPS (TTM): -4.57
PE ratio (TTM): N/A
Forward P/E: 24.47
Market cap: 463 543 258
Shares outstanding: 113 059 331
Dividend yield: N/A
Next earnings date: 2026-11-04
Sector: Healthcare
Industry: Health Information Services

About the company

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership a... read more

CEO: Seth Blackley
Country: United States
IPO Date: 2015-06-05
Employees: 4200
Fiscal Year End: January - December
Website: https://www.evolent.com

Revenue Breakdown

Performance Suite / 60.09%

Specialty Technology and Services Suite / 18.83%

Administrative Services / 12.08%

News

No Data

There are no news for this stock.

Chart: EVH

Loading Chart...

Overall Score

3.9 / 1039%

Octagon View

Strength & Weakness

Total debt $970.4M significantly exceeds cash reserves ($138.7M), raising financial stability concerns

Total current assets $610.5M exceed Total current liabilities $492.8M, highlighting excellent liquidity

Debt-to-equity ratio (2.5) far exceeds the industry average, reflecting over-leverage

Interest coverage ratio (-0.5x) is dangerously low, suggesting debt repayment risks

Negative free cash flow -$16.2M limits the company's ability to reinvest or pay down debt

Financial Strength

NAME	RATIO	INDUSTRY	SCORE
Current ratio	1.24	2.19	7.0
Quick ratio	1.24	1.96	7.0
Debt to Equity	2.53	1.16	2.0
Debt to Assets	0.49	2.94	5.0
Interest coverage	-0.52	-28.30	1.0
Weighted average score			4.4

Debt to Assets

Financial

Values in USD
(B=Billions, M=Millions, K=Thousands)

Values in USD (B=Billions, M=Millions, K=Thousands)

METRIC	2022	2023	2024	2025	TTM
Total Revenue	1.35B	1.96B	2.55B	1.88B	2.10B
Gross Profit	246M	337M	248M	284M	249M
Operating Income	5M	31M	2M	-4M	-28M
Net Income	-19M	-113M	-62M	-535M	-505M
EBITDA	95M	154M	126M	111M	88M

Current Ratio

Revenue & Net Income

Cashflow

Margin Ratios

Profitability

NAME	RATIO	INDUSTRY	SCORE
Gross margin %	9.08	50.96	3.0
Operating margin %	-1.34	-1.10	1.0
Net margin %	-4.35	-86.79	1.0
EBITDA margin %	1.97	-80.68	2.0
Cash flow margin %	-1.43	-79.21	1.0
Weighted average score			1.6

Net Margin

Effectiveness

NAME	RATIO	INDUSTRY	SCORE
ROA	-18.48	-89.91	1.0
ROE	-60.65	-19.58	1.0
ROIC	-26.24	96.58	1.0
ROCE	-0.47	31.74	1.0
Weighted average score			1.0

Estimated EPS vs Actual EPS

Forecast

NAME	REVENUE GROWTH	EPS GROWTH	SCORE
Current quarter	48.76	18.63	9.5
Next quarter	58.52	65.02	10
Current year	37.85	89.12	10
Next year	20.56	91.93	10
Weighted average score			9.9

Analyst Rating

Growth

NAME	REVENUE	NET INCOME	EPS	FCF	SCORE
Q/Q	31.49	-6.49	200	-118.68	5.5
Y/Y	46.86	-42.54	120	58.67	7.8
3y average	16.27	-409.17	-46.43	133.43	5.3
5y average	19.18	-219.46	924.04	13.56	7.0
Weighted average score					6.4

Revenue Growth Rate vs. Industry

Valuation

NAME	RATIO	INDUSTRY	SCORE
P/E	N/A	8.90	1.0
PEG (5yr expected)	1.93	0.70	5.0
P/S	0.21	17.85	10
P/B	1.16	1.55	7.0
Weighted average score			5.8

DCF Model

DCF Model Period5 years

Discount rate8.5%

Perpetual growth rate3%

Revenue 5 year CAGR18.17%

FCF 5 year CAGR4

Fair value4.1$

Stock price4.15$

Dividend

NAME	CURRENT	INDUSTRY	SCORE
Dividend yield	0.00	N/A	1.0
Payout ratio	0.00	N/A	1.0
5-year dividend growth rate	N/A	N/A	1.0
Years of dividend increase	N/A	N/A	1.0
Weighted average score			1.0

Fair Value

$4.1

UndervaluedStock priceOvervalued

$4.15

Economic Moat

NAME	SCALE	SCORE
Market share	None	1.0
Intangible assets	None	1.0
Switching costs	None	1.0
Network effect	None	1.0
Economies of scale	None	1.0
Weighted average score		1.0

About the company

CEO

Seth Blackley

Country

United States

IPO Date

2015-06-05

Employees

4200

Fiscal Year End

January - December

Website

https://www.evolent.com

NAME

RATIO

INDUSTRY

5Y TREND

SCORE

Current ratio

1.24

2.19

7.0

Quick ratio

1.24

1.96

7.0

Debt to Equity

2.53

1.16

2.0

Debt to Assets

0.49

2.94

5.0

Interest coverage

-0.52

-28.30

1.0

Weighted average score

4.4

METRIC

2022

2023

2024

2025

TTM

Total Revenue

1.35B

1.96B

2.55B

1.88B

2.10B

Gross Profit

246M

337M

248M

284M

249M

Operating Income

31M

-4M

-28M

Net Income

-19M

-113M

-62M

-535M

-505M

EBITDA

95M

154M

126M

111M

88M

NAME

RATIO

INDUSTRY

5Y TREND

SCORE

Gross margin %

9.08

50.96

3.0

Operating margin %

-1.34

-1.10

1.0

Net margin %

-4.35

-86.79

1.0

EBITDA margin %

1.97

-80.68

2.0

Cash flow margin %

-1.43

-79.21

1.0

Weighted average score

1.6

NAME

RATIO

INDUSTRY

5Y TREND

SCORE

ROA

-18.48

-89.91

1.0

ROE

-60.65

-19.58

1.0

ROIC

-26.24

96.58

1.0

ROCE

-0.47

31.74

1.0

Weighted average score

1.0

NAME

REVENUE GROWTH

EPS GROWTH

SCORE

Current quarter

48.76

18.63

9.5

Next quarter

58.52

65.02

Current year

37.85

89.12

Next year

20.56

91.93

Weighted average score

9.9

NAME

REVENUE

NET INCOME

EPS

FCF

SCORE

Q/Q

31.49

-6.49

200

-118.68

5.5

Y/Y

46.86

-42.54

120

58.67

7.8

3y average

16.27

-409.17

-46.43

133.43

5.3

5y average

19.18

-219.46

924.04

13.56

7.0

Weighted average score

6.4

NAME

RATIO

INDUSTRY

5Q TREND

SCORE

P/E

N/A

8.90

1.0

PEG (5yr expected)

1.93

0.70

5.0

P/S

0.21

17.85

P/B

1.16

1.55

7.0

Weighted average score

5.8

NAME

CURRENT

INDUSTRY

SCORE

Dividend yield

0.00

N/A

1.0

Payout ratio

0.00

N/A

1.0

5-year dividend growth rate

N/A

1.0

Years of dividend increase

N/A

1.0

Weighted average score

1.0

NAME

SCALE

SCORE

Market share

None

1.0

Intangible assets

None

1.0

Switching costs

None

1.0

Network effect

None

1.0

Economies of scale

None

1.0

Weighted average score

1.0

Search stocks

Evolent Health, Inc. (EVH)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Evolent Health, Inc. (EVH)

Stock details

About the company

Revenue Breakdown

News

Chart: EVH

Overall Score

Octagon View

Strength & Weakness

Financial Strength

Debt to Assets

Financial

Current Ratio

Revenue & Net Income

Cashflow

Margin Ratios

Profitability

Net Margin

Effectiveness

Estimated EPS vs Actual EPS

Forecast

Analyst Rating

Growth

Revenue Growth Rate vs. Industry

Valuation

DCF Model

Dividend

Fair Value

$4.1

$4.15

Economic Moat

Stock details

About the company

Revenue Breakdown

News

Chart: EVH

Overall Score

Octagon View

Strength & Weakness

Financial Strength

Debt to Assets

Financial

Current Ratio

Revenue & Net Income

Cashflow

Margin Ratios

Profitability

Net Margin

Effectiveness

Estimated EPS vs Actual EPS

Forecast

Analyst Rating

Growth

Revenue Growth Rate vs. Industry

Valuation

DCF Model

Dividend

Fair Value

$4.1

$4.15

Economic Moat